• Profile
Close

Cancer screening tests and cancer diagnoses during the COVID-19 pandemic

JAMA Jan 18, 2021

Bakouny Z, Paciotti M, Schmidt AL, et al. - In the largest health care system in the northeastern United States, Massachusetts General Brigham, this study evaluated the number of patients who underwent screening for cancer and of subsequent cancer diagnoses during the COVID-19 pandemic. During the four screening periods, 192,060 patients were screened. Findings suggest that during the COVID-19 pandemic, the number of patients undergoing screening tests for cancer and the number of subsequent diagnoses of cancerous and precancerous lesions were significantly reduced. From June to September 2020, a significant recovery was noted in the number of screening tests and subsequent diagnoses, almost to prepandemic levels. In addition, relative to expectations, a smaller number of possible “missed” diagnoses were likely during the primary pandemic period, given the higher percentage of screening tests resulting in a diagnosis of a cancerous or precancerous lesion during the primary pandemic period, which may suggest the prioritization of high-risk patients for cancer screening during the pandemic.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay